TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. PEMPHIGUS VULGARIS MARKET, BY TREATMENT TYPE (USD BILLION)
6.1. Corticosteroids
6.2. Immunosuppressants
6.3. Monoclonal Antibodies
6.4. Plasmapheresis
7. PEMPHIGUS VULGARIS MARKET, BY ROUTE OF ADMINISTRATION (USD BILLION)
7.1. Oral
7.2. Intravenous
7.3. Topical
8. PEMPHIGUS VULGARIS MARKET, BY PATIENT AGE GROUP (USD BILLION)
8.1. Pediatric
8.2. Adult
8.3. Geriatric
9. PEMPHIGUS VULGARIS MARKET, BY DISTRIBUTION CHANNEL (USD BILLION)
9.1. Hospital Pharmacy
9.2. Online Pharmacy
9.3. Retail Pharmacy
10. PEMPHIGUS VULGARIS MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Pemphigus Vulgaris Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Pemphigus Vulgaris Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. BristolMyers Squibb
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Sanofi
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. Takeda
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. Eli Lilly
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. GSK
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. Celgene
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. AbbVie
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. Sorrento Therapeutics
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. Amgen
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. Pfizer
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. Roche
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. Merck and Co
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. AstraZeneca
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. Novartis
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 6. NORTH AMERICA PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 7. US PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 8. US PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 9. US PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 10. US PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 11. US PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 12. CANADA PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 13. CANADA PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 14. CANADA PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 15. CANADA PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 16. CANADA PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 17. EUROPE PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 18. EUROPE PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 19. EUROPE PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 20. EUROPE PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 21. EUROPE PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 22. GERMANY PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 23. GERMANY PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 24. GERMANY PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 25. GERMANY PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 26. GERMANY PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 27. UK PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 28. UK PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 29. UK PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 30. UK PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 31. UK PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 32. FRANCE PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 33. FRANCE PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 34. FRANCE PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 35. FRANCE PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 36. FRANCE PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 37. RUSSIA PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 38. RUSSIA PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 39. RUSSIA PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 40. RUSSIA PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 41. RUSSIA PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 42. ITALY PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 43. ITALY PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 44. ITALY PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 45. ITALY PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 46. ITALY PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 47. SPAIN PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 48. SPAIN PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 49. SPAIN PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY PATIENT AGE GROUP, 2019-2032 (USD BILLIONS)
TABLE 50. SPAIN PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 51. SPAIN PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 52. REST OF EUROPE PEMPHIGUS VULGARIS MARKET SIZE ESTIMATES & FOR
